Physician profile
Daniel Buchnea
NPI 1184856965
$4,432.24
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $50.00 · 2022: $55.66 · 2023: $3,914 · 2024: $91.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $897 · Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $896.86 |
| Food and Beverage | $108.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,005.60 | 2023-2024 | Ion, Da Vinci Surgical System |
| Olympus Corporation of The Americas | $203.60 | 2019 | |
| Allergan, INC. | $101.50 | 2019 | |
| Genentech USA, INC. | $55.66 | 2022 | |
| Mylan Specialty L.P. | $30.00 | 2020 | |
| Insmed, INC. | $20.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Buchnea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.